MAYRA TORRES BRINK: Open Payments
NPI 1427399906 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,469 in 211 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $2,677 · 2025 $3,469
Food & beverage: $3,379Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $714 |
| Galderma Laboratories, L.P. | 37 | $506 |
| Regeneron Healthcare Solutions, Inc. | 9 | $310 |
| PFIZER INC. | 19 | $236 |
| Amgen Inc. | 6 | $214 |
| Lilly USA, LLC | 15 | $210 |
| Incyte Corporation | 11 | $207 |
| UCB, Inc. | 10 | $203 |
| LEO Pharma Inc. | 11 | $163 |
| Novartis Pharmaceuticals Corporation | 10 | $138 |
Products named: NEMLUVIO, DUPIXENT, SKYRIZI, CIBINQO, RINVOQ, OPZELURA, Bimzelx, OTEZLA.
Industry payments across ME — which companies pay providers there.
